Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Lengauer

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Seminars in Cancer Biology|December 23, 2004
Aneuploidy and genetic instability in cancerChristoph Lengauer
Science (New York, N.Y.)|April 19, 2003
Cancer. An unstable liaisonChristoph Lengauer
Cancer Chemotherapy and Pharmacology|August 17, 2004
CIN-ful cancersHarith Rajagopalan, Christoph Lengauer
Nature Genetics|October 30, 2004
From spindle checkpoint to cancerChristoph Lengauer, Zhenghe Wang
Nature|November 19, 2004
Aneuploidy and cancerHarith Rajagopalan, Christoph Lengauer
Cell Cycle (Georgetown, Tex.)|May 1, 2004
hCDC4 and genetic instability in cancerHarith Rajagopalan, Christoph Lengauer
Cancer Biology & Therapy|September 26, 2003
New paradigms for cancer drug discoveryJason A Sager, Christoph Lengauer
Cancer Biology & Therapy|September 26, 2003
New paradigms for cancer drug discoveryJason A Sager, Christoph Lengauer
Current Opinion in Oncology|November 29, 2007
Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and developmentSusan Wee, Christoph Lengauer, Dmitri Wiederschain
Nature Reviews. Drug Discovery|December 13, 2006
Why is cancer drug discovery so difficult?Alexander Kamb, Susan Wee, Christoph Lengauer
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Seminars in Cancer Biology|December 23, 2004
Aneuploidy and genetic instability in cancerChristoph Lengauer
Science (New York, N.Y.)|April 19, 2003
Cancer. An unstable liaisonChristoph Lengauer
Cancer Chemotherapy and Pharmacology|August 17, 2004
CIN-ful cancersHarith Rajagopalan, Christoph Lengauer
Nature Genetics|October 30, 2004
From spindle checkpoint to cancerChristoph Lengauer, Zhenghe Wang
Nature|November 19, 2004
Aneuploidy and cancerHarith Rajagopalan, Christoph Lengauer
Cell Cycle (Georgetown, Tex.)|May 1, 2004
hCDC4 and genetic instability in cancerHarith Rajagopalan, Christoph Lengauer
Cancer Biology & Therapy|September 26, 2003
New paradigms for cancer drug discoveryJason A Sager, Christoph Lengauer
Cancer Biology & Therapy|September 26, 2003
New paradigms for cancer drug discoveryJason A Sager, Christoph Lengauer
Current Opinion in Oncology|November 29, 2007
Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and developmentSusan Wee, Christoph Lengauer, Dmitri Wiederschain
Nature Reviews. Drug Discovery|December 13, 2006
Why is cancer drug discovery so difficult?Alexander Kamb, Susan Wee, Christoph Lengauer
Pageof 8